NeuPath Health Number Of Shares Shorted vs. Revenue
| NPTH Stock | CAD 0.17 0.01 6.25% |
For NeuPath Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of NeuPath Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well NeuPath Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between NeuPath Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of NeuPath Health over time as well as its relative position and ranking within its peers.
NeuPath |
NeuPath Health Revenue vs. Number Of Shares Shorted Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining NeuPath Health's current stock value. Our valuation model uses many indicators to compare NeuPath Health value to that of its competitors to determine the firm's financial worth. NeuPath Health is considered to be number one stock in number of shares shorted category among its peers. It also is rated top company in revenue category among its peers totaling about 418,367 of Revenue per Number Of Shares Shorted. At this time, NeuPath Health's Total Revenue is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NeuPath Health's earnings, one of the primary drivers of an investment's value.NeuPath Revenue vs. Number Of Shares Shorted
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
NeuPath Health |
| = | 158 |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
NeuPath Health |
| = | 66.1 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
NeuPath Revenue vs Competition
NeuPath Health is rated top company in revenue category among its peers. Market size based on revenue of Health Care industry is now estimated at about 3.83 Billion. NeuPath Health claims roughly 66.1 Million in revenue contributing just under 2% to equities under Health Care industry.
NeuPath Health Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in NeuPath Health, profitability is also one of the essential criteria for including it into their portfolios because, without profit, NeuPath Health will eventually generate negative long term returns. The profitability progress is the general direction of NeuPath Health's change in net profit over the period of time. It can combine multiple indicators of NeuPath Health, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Loss | -4.8 M | -5 M | |
| Income Tax Expense | 223.1 K | 234.3 K | |
| Net Interest Income | -919 K | -965 K | |
| Interest Income | 9 K | 8.6 K | |
| Operating Income | 442 K | 464.1 K | |
| Net Loss | -191 K | -200.6 K | |
| Income Before Tax | 55 K | 57.8 K | |
| Total Other Income Expense Net | 532 K | 558.6 K | |
| Net Loss | -107 K | -112.3 K | |
| Change To Netincome | 2.3 M | 2.3 M |
NeuPath Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on NeuPath Health. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of NeuPath Health position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the NeuPath Health's important profitability drivers and their relationship over time.
Use NeuPath Health in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NeuPath Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuPath Health will appreciate offsetting losses from the drop in the long position's value.NeuPath Health Pair Trading
NeuPath Health Pair Trading Analysis
The ability to find closely correlated positions to NeuPath Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NeuPath Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NeuPath Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NeuPath Health to buy it.
The correlation of NeuPath Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeuPath Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeuPath Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NeuPath Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your NeuPath Health position
In addition to having NeuPath Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Electrical Equipment Thematic Idea Now
Electrical Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Electrical Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electrical Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for NeuPath Stock Analysis
When running NeuPath Health's price analysis, check to measure NeuPath Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuPath Health is operating at the current time. Most of NeuPath Health's value examination focuses on studying past and present price action to predict the probability of NeuPath Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuPath Health's price. Additionally, you may evaluate how the addition of NeuPath Health to your portfolios can decrease your overall portfolio volatility.